18
Participants
Start Date
August 17, 2017
Primary Completion Date
September 19, 2018
Study Completion Date
September 19, 2018
TAK-935
TAK-935 tablets.
Placebo
TAK-935 placebo-matching tablets.
Thomas Jefferson University, Philadelphia
Mid-Atlantic Epilepsy and Sleep Center, Bethesda
University of Virginia Health Sciences Center, Charlottesville
Medical University of South Carolina, Charleston
Center for Integrative Rare Disease Research, Atlanta
University of South Florida, Tampa
Medsol Clinical Research Center, Port Charlotte
Bluegrass Epilepsy Research, Lexington
The Comprehensive Epilepsy Care Center for Children and Adults, St Louis
Xenoscience, Phoenix
Northeast Regional Epilepsy Group, Hackensack